Adam Muzikant
- Role
- Chief Business Officer at Avilar Therapeutics
- Location
- Boston, MA, US
- LinkedIn followers
- 500 followers
About Adam Muzikant
25+ years of executive leadership – ~20 years in BD and ~5 years in R&D – with a record…
Experience
Chief Business Officer
Jun 2022 — Present
Avilar Therapeutics is a biopharmaceutical company pioneering the discovery and development of extracellular protein degraders, a new frontier in targeted protein degradation. Avilar develops ATACs (ASGPR Targeting Chimeras), a new class of protein degraders that shuttle disease-causing proteins from circulation to the endolysosome where the unwanted proteins are degraded. Avilar has built a proprietary ATAC platform that includes novel, high-affinity, small molecule ASGPR ligands and advanced modeling of the biophysics, pharmacokinetics, and pharmacodynamics of ATAC mediated endocytosis and degradation. The ATAC platform enables the modular design and synthesis of ATACs extendable across the extracellular proteome to a wide range of proteins involved in the pathogenesis of human diseases. Avilar is leveraging the ATAC platform to create a broad and diverse pipeline of first-in-class extracellular protein degraders. Avilar was founded and financed by RA Capital Management
Education
UC San Diego
B.S., Engineering (Bioengineering) cum laude
1993
The Wharton School
Certificate, Finance and Accounting
Duke University
Ph.D., Biomedical Engineering
1998
Skills
- Clinical Development
- Partnerships
- Strategy
- Licensing
- Life Sciences
- Pharmaceutical Industry
- Drug Discovery
- Business Development
- Biotechnology
- Financial Modeling
- Biopharmaceuticals
- Commercialization
- Market Research
- Drug Development
- Mergers & Acquisitions
- Due Diligence
- Lifesciences
- Strategic Alliances
- Competitive Intelligence
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.